BrainsWay Reports Preliminary Record Fourth Quarter Revenue and Full-Year 2020 Financial Results
(NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced noninvasive treatment of brain disorders, today announced certain preliminary unaudited Fourth Quarter Financial Results.
- (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced noninvasive treatment of brain disorders, today announced certain preliminary unaudited Fourth Quarter Financial Results.
- As of December 31, 2020, BrainsWays Deep TMS installed base was 629 total systems after adding 36 systems during the fourth quarter, representing an increase of 18.7% compared to prior year results.
- These preliminary results should not be viewed as a substitute for the Companys fourth quarter reviewed and year end audited consolidated financial statements prepared in accordance with IFRS.
- Such statements may be preceded by the words intends, may, will, plans, expects, anticipates, projects, predicts, estimates, aims, believes, hopes, potential or similar words, and include statements regarding preliminary financial results for the fourth quarter revenue and full-year 2020 financial results.